Synthesis and in vitro antitumor activity of new deaza analogues of the nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine (PT523).
Synthesis and in vitro antitumor activity of new deaza analogues of the nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine (PT523).
复制标题
非聚谷氨酸抗叶酸剂 N(α)-(4-氨基-4-脱氧蝶酰基)-N(δ)-半邻苯二甲酰基-L-鸟氨酸 (PT523) 的新型脱氮类似物的合成和体外抗肿瘤活性。
DOI:
10.1021/jm010518t
复制
发表时间:
2002
影响因子:
7.3
通讯作者:
Rosowsky,Andre
中科院分区:
文献类型:
--
作者:
Vaidya,ChitraM;Wright,JoelE;Rosowsky,Andre
Details are disclosed for the synthesis ofNα-[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]-Nδ-hemiphthaloyl-l-ornithine (2) andNα-[4-[5-(2,4-diaminoteridin-6-yl)pent-1-yn-4-yl]benzoyl]-Nδ-hemiphthaloyl-l-ornithine (6) as analogues ofNα-(4-amino-4-deoxypteroyl)-Nδ-hemiphthaloyl-l-ornithine (1, PT523), a nonpolyglutamatable antifolate currently in advanced preclinical development. In a 72 h growth inhibition assay against cultures of CCRF-CEM human leukemic lymphoblasts, the IC50of2and6was 0.69 ± 0.044 nM and 1.3 ± 0.35 nM, respectively, as compared with previously reported values 4.4 ± 0.10 nM for aminopterin (AMT) and 1.5 ± 0.39 nM for PT523. In a spectrophotometric assay of dihydrofolate reductase (DHFR) inhibition using dihydrofolate and NADPH as the cosubstrates, the previously unreported compounds2and the mixed 10Rand 10Sdiastereomers of6hadKivalues of 0.21 ± 0.05 pM and 0.60 ± 0.02 pM, respectively, as compared with previously reported values of 3.70 ± 0.35 pM for AMT and 0.33 ± 0.04 pM for PT523. Thus, while they were comparable to1and several of its previously studied analogues in their ability to bind to DHFR and inhibit the growth of CCRF-CEM cells,2and the mixed diastereomers of6were several times more active than AMT despite the fact that they cannot form γ-polyglutamylated metabolites of the type formed in cells from AMT and other classical antifolates with a glutamate side chain.